Strength Seen in Idenix Pharmaceuticals (IDIX): Stock Surges 17.03%

Zacks


Idenix Pharmaceuticals Inc. (IDIX) was a big mover last session, as the company saw its shares jump 17% on the day. This rise can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $5.98 to $8.01 in the past one-month time frame. This sudden jump followed the company’s announcement of a direct stock offering, which will raise $106.7 million.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Idenix Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Actelion Ltd. (ALIOF), Gentium S.p.A (GENT) and Affymetrix Inc. (AFFX). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

 







IDENIX PHARMACEUTICALS INC (IDIX): Free Stock Analysis Report

GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

(AFFX): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)